Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023
23/1 12:25
Company Announcement Net sales of DARZALEX ® in 2023 totaled USD 9,744 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; January 23, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX ®...